Skip to main content
HairCited

Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders.

Janaya Nelson, Adam Friedman
Review Journal of drugs in dermatology : JDD 2026
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D41779767'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Loại nghiên cứu
Review
Đối tượng nghiên cứu
review of nonscarring eyebrow alopecia etiologies and management (1960-2025)
Can thiệp
Eyebrow Madarosis: An Updated Review of the Etiology and Management, Part I - Nonscarring Disorders. None
Đối chứng
None
Kết quả chính
None
Xu hướng hiệu quả
Neutral
Nguy cơ sai lệch
Unclear

Abstract

BACKGROUND: Eyebrow madarosis, or eyebrow alopecia, has significant cosmetic and psychosocial implications. Nonscarring causes are diverse, including autoimmune, infectious, endocrine, genetic, nutritional, traumatic, and iatrogenic etiologies. Despite its frequency in dermatologic practice, guidance for evaluation and management remains limited. METHODS: A comprehensive PubMed search (1960&ndash;2025) was performed using terms related to "eyebrow alopecia," "eyebrow madarosis," and specific disease processes. English-language studies were included if they evaluated eyebrow involvement and provided data on etiology, diagnosis, or treatment. Review articles without new patient data and studies limited to scalp alopecia were excluded. RESULTS: Nonscarring eyebrow alopecia can be caused by autoimmune disorders such as alopecia areata, infections including syphilis and tinea faciei, endocrinologic conditions like hypothyroidism, and inflammatory dermatoses such as atopic or seborrheic dermatitis. Additional causes include nutritional deficiencies, trauma, and drug-induced alopecia. Reported treatments include corticosteroids, calcineurin inhibitors, JAK inhibitors, immunomodulators, antifungals, zinc supplementation, and behavioral therapy. Novel agents such as dupilumab and roflumilast have shown promise for inflammatory-related eyebrow loss. CONCLUSION: Nonscarring eyebrow madarosis encompasses a wide range of reversible causes. Early recognition and targeted therapy can lead to eyebrow regrowth and improve psychosocial outcomes. Further studies are needed to establish evidence-based treatment algorithms and validated tools to assess eyebrow regrowth.

Tóm lược

Early recognition and targeted therapy can lead to eyebrow regrowth and improve psychosocial outcomes and further studies are needed to establish evidence-based treatment algorithms and validated tools to assess eyebrow regrowth.

Used In Evidence Reviews

Similar Papers